Comparing Cimzia vs Upadacitinib
| Cimzia (certolizumab) | Upadacitinib |
|
|---|
| Cimzia (certolizumab) | Upadacitinib |
|
|---|---|---|
|
Prescription only
Prescribed for Ankylosing Spondylitis, Crohn's Disease, Crohn's Disease - Active, Crohn's Disease - Maintenance, Non-Radiographic Axial Spondyloarthritis, Plaque Psoriasis, Polyarticular Juvenile... View more |
Prescription only
Prescribed for Crohn's Disease, Ankylosing Spondylitis, Atopic Dermatitis, Non-Radiographic Axial Spondyloarthritis, Giant Cell Arteritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic... View more |
Related suggestions Rheumatoid Arthritis
Crohn's Disease
Ankylosing Spondylitis
Popular comparisons
|
| More about Cimzia (certolizumab) | More about Upadacitinib | |
| Ratings & Reviews | ||
|
Cimzia has an average rating of 6.7 out of 10 from a total of 91 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 20% reported a negative effect. |
Upadacitinib has an average rating of 7.1 out of 10 from a total of 250 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 17% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all Cimzia side effects |
View all Upadacitinib side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
|
| Brand Names | ||
|
N/A |
Rinvoq, Rinvoq LQ | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
336 hours |
14 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 444 drugs are known to interact with Cimzia:
|
A total of 617 drugs are known to interact with Upadacitinib:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
| Disease Interactions | ||
| First Approval Date | ||
|
April 22, 2008 |
August 16, 2019 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.